Zipfel Burkhart, Hammerschmidt Robert, Krabatsch Thomas, Buz Semih, Weng Yuguo, Hetzer Roland
Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum Berlin, Berlin, Germany.
Ann Thorac Surg. 2007 Feb;83(2):441-8; discussion 448-9. doi: 10.1016/j.athoracsur.2006.09.036.
We evaluated endovascular stent-grafting as a new technique in aortic surgery.
One hundred ninety-six stent-grafts were implanted in the thoracic aorta in 172 patients. All procedures but one were performed in the operating room by a team of cardiothoracic surgeons; 112 operations (57%) were emergency procedures. Twenty-four procedures (12%) were reoperations for endoleaks. The left subclavian artery origin was covered in 46 cases and the left common carotid artery in 2 cases. Access was by femoral cut-down in 174 procedures, percutaneous femoral approach in 1, and by conduit to the iliac arteries or infrarenal aorta in 17. Surgical reconstruction of damaged access vessels became necessary in 10 cases.
Thirty-day mortality was 9.7% (19 patients). Paraplegia occurred in 1.0% (2 patients). Primary technical success was 85.2%, secondary 91.8%. Six conversions to open repair were necessary, 3 during the procedures and 3 secondarily before discharge. Actuarial survival was 79% at 1 year, 67% at 3 years, and 55% at 5 years.
The results are excellent, taking into account the high incidence of emergency procedures and that open surgery is not promising in many patients. The cardiothoracic surgeon can perform the procedure after adequate training in endovascular techniques. Surgical skills are mandatory because of the potential need for extended surgical approach to the access vessels or immediate conversion to open surgery. Therefore, the operating room is the preferred site for this procedure.
我们评估了血管内支架植入术作为主动脉手术的一项新技术。
172例患者的胸主动脉植入了196个支架移植物。除1例手术外,所有手术均由心胸外科医生团队在手术室进行;112例手术(57%)为急诊手术。24例手术(12%)因内漏而行再次手术。46例覆盖左锁骨下动脉起始部,2例覆盖左颈总动脉。174例手术经股动脉切开入路,1例经皮股动脉入路,17例经导管至髂动脉或肾下腹主动脉入路。10例患者需要对受损的入路血管进行手术重建。
30天死亡率为9.7%(19例患者)。截瘫发生率为1.0%(2例患者)。一期技术成功率为85.2%,二期为91.8%。有6例需要转为开放修复,3例在手术过程中,3例在出院前二期转为开放修复。1年、3年和5年的预期生存率分别为79%、67%和55%。
考虑到急诊手术的高发生率以及开放手术对许多患者并不适用,结果非常理想。心胸外科医生在接受充分的血管内技术培训后可以开展该手术。由于可能需要对入路血管进行扩大手术或立即转为开放手术,手术技能是必不可少的。因此,手术室是进行该手术的首选场所。